Quantification of Dolichyl Phosphates Using Phosphate Methylation and Reverse-Phase Liquid Chromatography-High Resolution Mass Spectrometry

dc.bibliographicCitation.firstPage3210
dc.bibliographicCitation.issue6
dc.bibliographicCitation.journalTitleAnalytical chemistry : the authoritative voice of the analytical communityeng
dc.bibliographicCitation.lastPage3217
dc.bibliographicCitation.volume95
dc.contributor.authorKale, Dipali
dc.contributor.authorKikul, Frauke
dc.contributor.authorPhapale, Prasad
dc.contributor.authorBeedgen, Lars
dc.contributor.authorThiel, Christian
dc.contributor.authorBrügger, Britta
dc.date.accessioned2023-06-02T15:00:33Z
dc.date.available2023-06-02T15:00:33Z
dc.date.issued2023
dc.description.abstractDolichyl monophosphates (DolPs) are essential lipids in glycosylation pathways that are highly conserved across almost all domains of life. The availability of DolP is critical for all glycosylation processes, as these lipids serve as membrane-anchored building blocks used by various types of glycosyltransferases to generate complex post-translational modifications of proteins and lipids. The analysis of DolP species by reverse-phase liquid chromatography-mass spectrometry (RPLC-MS) remains a challenge due to their very low abundance and wide range of lipophilicities. Until now, a method for the simultaneous qualitative and quantitative assessment of DolP species from biological membranes has been lacking. Here, we describe a novel approach based on simple sample preparation, rapid and efficient trimethylsilyl diazomethane-dependent phosphate methylation, and RPLC-MS analysis for quantification of DolP species with different isoprene chain lengths. We used this workflow to selectively quantify DolP species from lipid extracts derived of Saccharomyces cerevisiae, HeLa, and human skin fibroblasts from steroid 5-α-reductase 3- congenital disorders of glycosylation (SRD5A3-CDG) patients and healthy controls. Integration of this workflow with global lipidomics analyses will be a powerful tool to expand our understanding of the role of DolPs in pathophysiological alterations of metabolic pathways downstream of HMG-CoA reductase, associated with CDGs, hypercholesterolemia, neurodegeneration, and cancer.eng
dc.description.versionpublishedVersioneng
dc.identifier.urihttps://oa.tib.eu/renate/handle/123456789/12267
dc.identifier.urihttp://dx.doi.org/10.34657/11299
dc.language.isoeng
dc.publisherColumbus, Ohio : American Chemical Society
dc.relation.doihttps://doi.org/10.1021/acs.analchem.2c03623
dc.relation.essn1520-6882
dc.relation.issn0003-2700
dc.rights.licenseCC BY-NC-ND 4.0 Unported
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.subject.ddc540
dc.subject.otherAlkylationeng
dc.subject.otherBiological membraneseng
dc.subject.otherCell cultureeng
dc.subject.otherGlycosylationeng
dc.subject.otherLiquid chromatographyeng
dc.titleQuantification of Dolichyl Phosphates Using Phosphate Methylation and Reverse-Phase Liquid Chromatography-High Resolution Mass Spectrometryeng
dc.typeArticleeng
dc.typeTexteng
tib.accessRightsopenAccess
wgl.contributorISAS
wgl.subjectChemieger
wgl.typeZeitschriftenartikelger
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Quantification_of_Dolichyl_Phosphates.pdf
Size:
1.79 MB
Format:
Adobe Portable Document Format
Description:
Collections